Efficacy and safety of bevacizumab-combined single-agent chemotherapy for platinum-resistant ovarian cancer that recurred during PARP inhibitor treatment

  1. Eriko Takatori
  2. Tadahiro Shoji
  3. Ami Jo
  4. Miku Musashi
  5. Shunsuke Tatsuki
  6. Nanako Jonai
  7. Yohei Chiba
  8. Sho Sato
  9. Yoshitaka Kaido
  10. Takayuki Nagasawa
  11. Masahiro Kagabu
  12. Fumiaki Takahashi
  13. Takeshi Aida
  14. Tsukasa Baba
Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1007/s10147-026-02959-7
  2. Version published to 10.21203/rs.3.rs-7904976/v1 on Research Square